Pharvaris (PHVS) Retained Earnings (2019 - 2026)
Pharvaris (PHVS) posted Retained Earnings of $61.9 million for Q1 2026, up 4.8% on a QoQ basis from $59.1 million in Q4 2025, and up 36.69% year-over-year from $45.3 million in Q1 2025.
Pharvaris (PHVS) Retained Earnings (2019 - 2026) Analysis & Trends
Pharvaris' Retained Earnings history runs 8 years deep, the most recent figure standing at $61.9 million for Q1 2026.
- Quarterly Retained Earnings rose 36.69% year-over-year to $61.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.9 million (up 36.69% YoY) and the FY2025 annual result came in at $57.4 million, up 33.45% from the prior year.
- Retained Earnings was $61.9 million for Q1 2026 at Pharvaris, up from $59.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $61.9 million in Q1 2026 and bottomed at $13.2 million in Q1 2022.
- A 5-year average of $35.1 million and a median of $32.4 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 169.86% — and 2024, when it soared 30.36%.
- Pharvaris' Retained Earnings stood at $20.6 million in 2022, then jumped by 45.85% to $30.0 million in 2023, then surged by 41.39% to $42.4 million in 2024, then soared by 39.26% to $59.1 million in 2025, then increased by 4.8% to $61.9 million in 2026.
- Business Quant data shows PHVS's Retained Earnings at $61.9 million in Q1 2026, $59.1 million in Q4 2025, and $55.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | 61.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.93 Mn |
| Dec 31, 2025 | 59.09 Mn |
| Sep 30, 2025 | 55.61 Mn |
| Jun 30, 2025 | 50.13 Mn |
| Mar 31, 2025 | 45.31 Mn |
| Dec 31, 2024 | 42.44 Mn |
| Sep 30, 2024 | 39.72 Mn |
| Jun 30, 2024 | 34.42 Mn |
| Mar 31, 2024 | 32.44 Mn |
| Dec 31, 2023 | 30.01 Mn |
| Sep 30, 2023 | 28.50 Mn |
| Jun 30, 2023 | 26.41 Mn |
| Mar 31, 2023 | 24.12 Mn |
| Dec 31, 2022 | 20.58 Mn |
| Sep 30, 2022 | 17.56 Mn |
| Jun 30, 2022 | 15.70 Mn |
| Mar 31, 2022 | 13.16 Mn |
| Dec 31, 2021 | 11.18 Mn |
| Sep 30, 2021 | 9.55 Mn |
| Jun 30, 2021 | 6.93 Mn |